USPTO trademark

KANMIRY

Awaiting publicationUSPTOWord markClass 5

"KANMIRY" is a word mark owned by Eli Lilly and Company, filed at the USPTO on September 11, 2026. It is waiting to be published and covers class 5 (Pharmaceuticals).

View Eli Lilly and Company portfolioGet this data via the API
Official USPTO record
KANMIRY trademark as filed
As filed with the USPTO
Status
Awaiting publication
Since October 27, 2026
Filed
September 11, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50102431
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns KANMIRY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Eli Lilly and Company

LLY · Indianapolis, United States

8,043 trademarks in the portfolioView company

Representative

John R. Rudolph

Goods and services

What the mark covers

The products and services KANMIRY is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer's disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, infectious diseases, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, opioid use disorder, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, pulmonary diseases, retinal disease, rheumatoid arthritis, tobacco use disorder, ulcerative colitis, vascular diseases and vision loss; pharmaceutical preparations for weight management; vaccines for human use

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Approved for pub - principal register
  2. Assigned to examiner
  3. Application filing receipt mailed
  4. New application office supplied data entered
  5. New application entered
FAQ

About KANMIRY

Who owns the trademark "KANMIRY"?

The USPTO trademark "KANMIRY" (application 50102431) is owned by Eli Lilly and Company.

What is the status of "KANMIRY"?

Its status at the USPTO is: awaiting publication.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull KANMIRY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a095ba-5a34-70bf-b087-6a29b1d9c13f
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a095ba-5a34-70bf-b087-6a29b1d9c13f",
  "object": "trademark",
  "mark_text": "KANMIRY",
  "status": {
    "primary": "pending",
    "stage": "pending_publication"
  },
  "office_code": "US",
  "application_number": "50102431",
  "filing_date": "2026-09-11",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Eli Lilly and Company",
      "entity_id": "ent_019eb749-c2e4-7669-8d85-00996fda299e"
    }
  ]
}